Edesa Biotech, Inc.·4

Jun 2, 9:00 PM ET

Weiler Peter J. 4

4 · Edesa Biotech, Inc. · Filed Jun 2, 2025

Insider Transaction Report

Form 4
Period: 2025-05-29
Weiler Peter J.
Chief Financial Officer
Transactions
  • Award

    Common Shares

    2025-05-29+65,00065,000 total
Footnotes (1)
  • [F1]Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary